Laid off from West Pharmaceutical Services.

What West Pharmaceutical Services layoffs have meant for employees

Both of West's cost-base plans rest on one sentence. Its 10-K for 2022 and its 10-Q for September 2026 say West approved one in December 2022 and the other in January 2025 “to adjust our operating cost base to better respond to the macroeconomic factors influencing our business,” a reason that ties the cuts to the economy and to West's costs and singles out no plant or product. If you work at West, the newer plan's timetable says more. West expected to carry it out over 24 to 36 months, a window that by our count closes between January 2027 and January 2028, and by September 30, 2026 it had booked just over half the plan's estimated charge, including $3.8 million of new severance and benefits charges in 2026. In September West added the consolidation of manufacturing sites to it, without naming any. A separate plan for the SmartDose sale, approved in December 2025, was given its own 12 to 15 months.

West's restructurings have pulled Scottsdale in two directions. Its December 2007 8-K planned to bring tool production from two sites together at a facility in the city while trimming the Tech Group unit, and in 2026 West was phasing out SmartDose production at its Scottsdale operations after selling the device's manufacturing rights and its Tempe plant to AbbVie, Plastics News reported. Eric Green, West's chief executive when the deal was signed, said a portfolio review led to it, as Drug Delivery Business quoted him. The sale treated the two sites differently. The Tempe plant changed owners along with its production lines, and AbbVie's January 2026 announcement put its planned hiring at the site at about 200 people, without saying whether West's Tempe staff would be among them. In 2026 West paid out $2.7 million of the $4.2 million in severance and benefits obligations it carried into the year under the December 2025 plan for that sale.

Contract manufacturing, making parts and assemblies to other companies' orders, runs through several of West's cuts. Montgomery and Frankfort, which West decided to close in 2010 and 2018, both did that work, as West's December 2010 8-K and Inside INdiana Business described them, and the plan in the November 2009 8-K set out to consolidate Tech Group operations to match capacity to the contract-manufacturing activity West expected. The 2007 Tech Group plan answered a drop in business that West put down to changes in its customers' marketing plans. The 2026 cut broke from that pattern. SmartDose was a device West says it pioneered, and its Scottsdale production was phased out after a sale. If your West job makes products for another company, that customer's plans are worth following alongside West's own.

West's plant closings have been planned in stages. Frankfort's 2018 layoffs were planned in four groups through the end of November, and virtually all of its Clinton County positions were to go after October 1, Inside INdiana Business reported, while Montgomery's changes were set to run from early 2011 to the end of 2012. If you've had a notice from a West site that's winding down, it's reasonable to ask West to confirm which group you're in and your effective date.

West has planned before to move work from one of its plants to others. A 2009 plan called for moving some Montgomery products to other Tech Group plants a year before the closing was approved, and the 2010 plan expected the remaining Montgomery and Cornwall work to end or move to other West operations, predominantly in Europe and the United States.